Raffi Asadorian - 03 Mar 2022 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (TLPH)

Role
Chief Financial Officer
Signature
/s/ Martha Adler, Attorney-In-Fact
Issuer symbol
TLPH
Transactions as of
03 Mar 2022
Net transactions value
-$3,223
Form type
4
Filing time
04 Mar 2022, 15:25:05 UTC
Previous filing
14 Feb 2022
Next filing
08 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRX Common Stock Tax liability $3,223 -7,923 -2.1% $0.4068 364,205 03 Mar 2022 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
F2 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
F3 Balance includes non-reportable acquisition of 4,040 shares of Common Stock through the Company's Employee Stock Purchase Plan.
F4 On February 14, 2022, the reporting person filed a Form 4 which inadvertently under-reported his holdings in the Issuer by 8 shares. In addition to reporting the current transactions, this Form 4 serves to correct the reporting person's holdings in the Issuer.